secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lexaria Bioscience Corp. (LEXX)
CIK:        0001348362
Form:       8-K
Filed at:   2024-04-24T23:59:59+00:00
Accession:  0001640334-24-000702
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Lexaria Bioscience shareholders elect all six directors and ratify auditor at annual meeting
--------------------------------------------------------------------------------

- All six director nominees elected with 85-99% support: Bunka, Docherty, Baxter, McKechnie, Reese Jr., Turkel.
- Malone Bailey LLP ratified as auditors with 99% of votes cast.
- Ratification of directors' actions passed with 97% of votes cast.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1348362/000164033424000702/0001640334-24-000702-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1348362/000164033424000702/lxrp_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-24-000702

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer